CLASS II ONGOING Device recall · Reported 29 Oct 2025 · FDA Enforcement Report

Artegraft¿ Collagen Vascular Graft recalled by LeMaitre Vascular

LeMaitre Vascular is recalling Artegraft¿ Collagen Vascular Graft, distributed in Arkansas. The recall was initiated on 25 Sep 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF: AG1015; UDI-DI: 00316837000343; Lot/Serial Number: 23MM581-016;
Quantity recalled1 unit

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0289-2026
FDA event ID
97700
Recalling firm
LeMaitre Vascular, North Brunswick, NJ
Classification
Class II
Status
Ongoing
Recall initiated
25 Sep 2025
FDA classified
23 Oct 2025
Reported
29 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

25 Sep 2025Recall initiated by company
23 Oct 2025Classified by FDA+28 days
29 Oct 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The device was incorrectly packed in the wrong size labeled outer packaging.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Artegraft¿ Collagen Vascular Graft; REF: AG1015;

Where it was distributed

US distribution to the state of: AR

Arkansas

Questions about this recall

Why was it recalled?

The device was incorrectly packed in the wrong size labeled outer packaging.

Which lots are affected?

REF: AG1015; UDI-DI: 00316837000343; Lot/Serial Number: 23MM581-016;

Where was it sold?

US distribution to the state of: AR

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from LeMaitre Vascular

All 71

Other Heart & Vascular Devices recalls

All 6,220